A look at how AI is reshaping the landscape of drug discovery, allowing researchers to approach complex diseases with newfound precision.Thras Karydis, Chief Technology Officer at DeepCure, will explain DeepCure’s technology, the role of AI in modern pharmaceuticals, and the company’s mission to tackle unmet medical needs faster and more effectively than traditional methods.
